MedMira Inc. | Income Statement

Fiscal year is August-July. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,001.50
2,528.20
4,052.30
2,256.80
747.30
588.90
Cost of Goods Sold (COGS) incl. D&A
1,669.90
436.40
1,066.70
999.40
983.20
562
Gross Income
331.60
2,091.80
2,985.60
1,257.40
235.90
26.90
SG&A Expense
2,496.90
5,660.40
5,727.10
5,736.30
1,931.30
1,785.90
EBIT
2,165.40
3,568.60
-
4,478.90
2,167.20
1,759
Unusual Expense
2,497.70
479.80
-
260.00
78.00
28
Non Operating Income/Expense
-
-
11.10
0.00
34.10
81.30
Interest Expense
734.60
760.70
769.20
939.60
449.90
697.20
Pretax Income
402.30
3,835.30
3,499.60
5,158.40
2,661.10
2,509.50
Consolidated Net Income
402.30
3,835.30
3,499.60
5,158.40
2,661.10
2,509.50
Net Income
402.30
3,835.30
3,499.60
5,158.40
2,661.10
2,509.50
Net Income After Extraordinaries
402.30
3,835.30
3,499.60
5,158.40
2,661.10
2,509.50
Net Income Available to Common
402.30
3,835.30
3,499.60
5,158.40
2,661.10
2,509.50
EPS (Basic)
0.00
0.01
0.01
0.01
0.00
-
Basic Shares Outstanding
392,264.30
514,364.30
558,364.30
658,364.30
658,364.30
658,364.30
EPS (Diluted)
0.00
0.01
0.01
0.01
0.00
-
Diluted Shares Outstanding
392,264.30
514,364.30
558,364.30
658,364.30
658,364.30
658,364.30
EBITDA
2,124.60
3,482.30
2,647.40
4,379.10
2,068.40
1,692.20
Non-Operating Interest Income
-
14.20
-
-
-
-

About MedMira

View Profile
Address
155 Chain Lake Drive
Halifax Nova Scotia B3S 1B3
Canada
Employees -
Website http://www.medmira.com
Updated 07/08/2019
MedMira, Inc. engages in the research, development, manufacture, and commercialization of rapid diagnostics and technology platforms. Its tests provide hospitals, labs, clinics, and individuals with rapid diagnosis for diseases, including human immunodeficiency virus and hepatitis C. It offers its tests under the Reveala, Multiplo, and Miriad brands.